Oncology and Hematology

Episodes 193-208 of 463

• 

  RestartResume

  Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR

  RestartResume

  Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR

  GI Insights

  Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR

  • 

    

    Peter Buch, MD, FACG, AGAF, FACP

  • 

    

    Vivek Kaul, MD

• 

  RestartResume

  Chemotherapy Strategies for Metastatic PDAC

  RestartResume

  Chemotherapy Strategies for Metastatic PDAC

  MinuteCE®

  Chemotherapy Strategies for Metastatic PDAC

  0.25 program credits

  • 

    

    Efrat Dotan, MD

  • 

    

    Shubham Pant, MD, MBBS

  0.25 program credits

• 

  MinuteCE®

  Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment

  0.25 credits 2 episodes

  • 

    

    Efrat Dotan, MD

  • 

    

    Shubham Pant, MD, MBBS

  0.25 credits 2 episodes

• 

  RestartResume

  Diagnosis and Management of Metastatic PDAC

  RestartResume

  Diagnosis and Management of Metastatic PDAC

  MinuteCE®

  Diagnosis and Management of Metastatic PDAC

  0.25 program credits

  • 

    

    Efrat Dotan, MD

  • 

    

    Shubham Pant, MD, MBBS

  0.25 program credits

• 

  RestartResume

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

  RestartResume

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

  Project Oncology®

  Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia

• 

  RestartResume

  Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions 

  RestartResume

  Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions 

  Global Oncology Academy

  Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions 

• 

  RestartResume

  Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges

  RestartResume

  Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges

  Project Oncology®

  Early-Stage Breast Cancer Care: Treatment Selection Strategies and Challenges

  • 

    

    Adrienne Waks, MD

• 

  RestartResume

  Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence     

  RestartResume

  Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence     

  MinuteCE®

  Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence     

  1.25 program credits

  • 

    

    Sara Lonardi, MD

  1.25 program credits

• 

  RestartResume

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  RestartResume

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  MinuteCE®

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  1.25 program credits

  • 

    

    Aparna R. Parikh, MD

  1.25 program credits

• 

  RestartResume

  Emerging Treatment Approaches for EBC

  RestartResume

  Emerging Treatment Approaches for EBC

  MinuteCE®

  Emerging Treatment Approaches for EBC

  1.50 program credits

  • 

    

    William J. Gradishar, MD

  1.50 program credits

• 

  RestartResume

  Management of HR+, HER2- High-Risk EBC 

  RestartResume

  Management of HR+, HER2- High-Risk EBC 

  MinuteCE®

  Management of HR+, HER2- High-Risk EBC 

  1.50 program credits

  • 

    

    Erica L. Mayer, MD, MPH

  1.50 program credits

• 

  RestartResume

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  RestartResume

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  MinuteCE®

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  1.25 program credits

  • 

    

    Aparna R. Parikh, MD

  1.25 program credits

• 

  RestartResume

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  RestartResume

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  MinuteCE®

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  1.25 program credits

  • 

    

    Sara Lonardi, MD

  1.25 program credits

• 

  RestartResume

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  RestartResume

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  MinuteCE®

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  1.25 program credits

  • 

    

    Alan Venook, MD

  1.25 program credits

• 

  RestartResume

  Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC  

  RestartResume

  Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC  

  MinuteCE®

  Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC  

  1.50 program credits

  • 

    

    Peter Schmid, FRCP, MD, PhD

  1.50 program credits

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Gastrointestinal Cancers

  1.25 credits 10 episodes

  • 

    

    Sara Lonardi, MD

  • 

    

    Aparna R. Parikh, MD

  • 

    

    Alan Venook, MD

  1.25 credits 10 episodes

• Previous
• 1
• 2
• …
• 11
• 12
• 13
• 14
• 15
• …
• 28
• 29
• Next